MAOB and early-onset autosomal dominant Alzheimer disease: Firstly, the small sample size in all studies necessitates careful interpretation of the results for both tracers, particularly for 18F-SMBT-1, where the very limited number of individuals hinders more detailed comparisons within these often heterogeneous in terms of MAO-B load subgroups of patients with MCI + and Alzheimer’s disease [44].